Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Bullboard Posts
Post by spirdolaion Dec 13, 2007 1:49pm
116 Views
Post# 14015743

China

ChinaLets hope this happens to our Microbix, wishing for a nice Chirstmas suprise.

This could be whly Gastle commented about China.

Stockhouse U.S. Small and Micro-cap Stock Report for Tuesday, December 11, 2007

TORONTO (SHfn) – Speculators were high on vaccines in China Tuesday.

Sinovac Biotech (AMEX: SVA, Bullboards) shares shot up 23% to $4.35 on Tuesday after the provider of vaccines in China reported third-quarter sales that soared 141% year-over-year to $10.8 million, while gross profit grew 266% year-over-year to $9.2 million.

Bullboard Posts